British Journal of Pharmacology

Cover image for Vol. 174 Issue 8

Early View (Online Version of Record published before inclusion in an issue)

Editor-in-Chief: Professor A. Ahluwalia

Impact Factor: 5.259

ISI Journal Citation Reports © Ranking: 2015: 17/255 (Pharmacology & Pharmacy)

Online ISSN: 1476-5381

Associated Title(s): British Journal of Clinical Pharmacology, Pharmacology Research & Perspectives

VIEW

  1. 1 - 97
  1. RESEARCH PAPERS

    1. Inhibition of 6-phosphofructo-2-kinase suppresses fibroblast-like synoviocytes-mediated synovial inflammation and joint destruction in rheumatoid arthritis

      Yaoyao Zou, Shan Zeng, Mingcheng Huang, Qian Qiu, Youjun Xiao, Maohua Shi, Zhongping Zhan, Liuqin Liang, Xiuyan Yang and Hanshi Xu

      Version of Record online: 27 MAR 2017 | DOI: 10.1111/bph.13762

      • image
      • image
      • image
      • image
      • image
      • image
      • image
      • image
  2. DRUG REPURPOSING

    1. Opportunities for the repurposing of PARP inhibitors for the therapy of non-oncological diseases

      Nathan A Berger, Valerie C Besson, A Hamid Boulares, Alexander Bürkle, Alberto Chiarugi, Robert S Clark, Nicola J Curtin, Salvatore Cuzzocrea, Ted M Dawson, Valina L Dawson, György Haskó, Lucas Liaudet, Flavio Moroni, Pál Pacher, Peter Radermacher, Andrew L Salzman, Solomon H Snyder, Francisco Garcia Soriano, Robert P Strosznajder, Balázs Sümegi, Raymond A Swanson and Csaba Szabo

      Version of Record online: 26 MAR 2017 | DOI: 10.1111/bph.13748

      • image
      • image
      • image
  3. RESEARCH PAPERS

    1. PGE2/EP4 receptor attenuated mucosal injury via β-arrestin1/Src/EGFR-mediated proliferation in portal hypertensive gastropathy

      Siwei Tan, Xiaoliang Chen, Minyi Xu, Xiaoli Huang, Huiling Liu, Jie Jiang, Yu Lu, Xiaojie Peng and Bin Wu

      Version of Record online: 25 MAR 2017 | DOI: 10.1111/bph.13752

      • image
      • image
      • image
      • image
      • image
      • image
      • image
      • image
      • image
      • image
  4. SPOTLIGHT ON SMALL MOLECULES IN CARDIOVASCULAR DISEASES

    1. Metformin attenuates angiotensin II-induced TGFβ1 expression by targeting hepatocyte nuclear factor-4-α

      Ruifei Chen, Yenan Feng, Jimin Wu, Yao Song, Hao Li, Qiang Shen, Dan Li, Jianshu Zhang, Zhizhen Lu, Han Xiao and Youyi Zhang

      Version of Record online: 24 MAR 2017 | DOI: 10.1111/bph.13753

      • image
      • image
      • image
      • image
      • image
      • image
  5. TARGETING ION CHANNELS TO TREAT CHRONIC PAIN

    1. Calcium signalling through L-type calcium channels: role in pathophysiology of spinal nociceptive transmission

      Olivier Roca-Lapirot, Houda Radwani, Franck Aby, Frédéric Nagy, Marc Landry and Pascal Fossat

      Version of Record online: 24 MAR 2017 | DOI: 10.1111/bph.13747

      • image
      • image
  6. RESEARCH PAPERS

    1. Stimulation of Na+-K+-pump currents by epithelial nicotinic receptors in rat colon

      Sandra Bader, Lena Lottig and Martin Diener

      Version of Record online: 23 MAR 2017 | DOI: 10.1111/bph.13761

      • image
      • image
      • image
      • image
      • image
      • image
      • image
    2. Transient Receptor Potential Cation Channel Subfamily M Member 8 channels mediate the anti-inflammatory effects of eucalyptol

      Ana I Caceres, Boyi Liu, Sairam V Jabba, Satyanarayana Achanta, John B Morris and Sven-Eric Jordt

      Version of Record online: 23 MAR 2017 | DOI: 10.1111/bph.13760

      • image
      • image
      • image
      • image
      • image
      • image
      • image
      • image
  7. EMERGENT AREAS OF OPIOID PHARMACOLOGY

    1. Opioids and the immune system – friend or foe

      Lisanne Mirja Plein and Heike L Rittner

      Version of Record online: 23 MAR 2017 | DOI: 10.1111/bph.13750

      • image
      • image
      • image
  8. DRUG REPURPOSING

  9. DRUG METABOLISM AND ANTIBIOTIC RESISTANCE IN MICRO-ORGANISMS

    1. You have full text access to this OnlineOpen article
      Identification of the anti-mycobacterial functional properties of piperidinol derivatives

      Collette S Guy, Esther Tichauer, Gemma L Kay, Daniel J Phillips, Trisha L Bailey, James Harrison, Christopher M Furze, Andrew D Millard, Matthew I Gibson, Mark J Pallen and Elizabeth Fullam

      Version of Record online: 23 MAR 2017 | DOI: 10.1111/bph.13744

      • image
      • image
      • image
  10. TARGETING INFLAMMATION TO REDUCE CVD RISK: A REALISTIC CLINICAL PROSPECT

    1. You have free access to this content
      Current and future therapies for addressing the effects of inflammation on HDL cholesterol metabolism

      Fatima Iqbal, Wendy S Baker, Madiha I Khan, Shwetha Thukuntla, Kevin H McKinney, Nicola Abate and Demidmaa Tuvdendorj

      Version of Record online: 23 MAR 2017 | DOI: 10.1111/bph.13743

      • image
    2. Sitagliptin reduces inflammation, fibrosis and preserves diastolic function in a rat model of heart failure with preserved ejection fraction

      Grazia Esposito, Donato Cappetta, Rosa Russo, Alessia Rivellino, Loreta Pia Ciuffreda, Fiorentina Roviezzo, Elena Piegari, Liberato Berrino, Francesco Rossi, Antonella De Angelis and Konrad Urbanek

      Version of Record online: 21 MAR 2017 | DOI: 10.1111/bph.13686

      • image
      • image
      • image
      • image
      • image
      • image
      • image
  11. REVIEW ARTICLES

    1. Utilizing melatonin to combat bacterial infections and septic injury

      Wei Hu, Chao Deng, Zhiqiang Ma, Dongjin Wang, Chongxi Fan, Tian Li, Shouyin Di, Bing Gong, Russel J Reiter and Yang Yang

      Version of Record online: 21 MAR 2017 | DOI: 10.1111/bph.13751

      • image
      • image
      • image
  12. RESEARCH PAPERS

    1. Neurochemical and behavioural effects of hypidone hydrochloride (YL-0919): a novel combined selective 5-HT reuptake inhibitor and partial 5-HT1A agonist

      Li-Ming Zhang, Xiao-Yun Wang, Nan Zhao, Yu-Lu Wang, Xiao-Xu Hu, Yu-Hua Ran, Yan-Qin Liu, You-Zhi Zhang, Ri-Fang Yang and Yun-Feng Li

      Version of Record online: 21 MAR 2017 | DOI: 10.1111/bph.13675

      • image
      • image
      • image
      • image
      • image
      • image
  13. NICOTINIC ACETYCHOLINE RECEPTORS

  14. TARGETING ION CHANNELS TO TREAT CHRONIC PAIN

    1. Homology-guided mutational analysis reveals the functional requirements for antinociceptive specificity of collapsin response mediator protein 2-derived peptides

      Aubin Moutal, Wennan Li, Yue Wang, Weina Ju, Shizhen Luo, Song Cai, Liberty François-Moutal, Samantha Perez-Miller, Jackie Hu, Erik T Dustrude, Todd W Vanderah, Vijay Gokhale, May Khanna and Rajesh Khanna

      Version of Record online: 17 MAR 2017 | DOI: 10.1111/bph.13737

      • image
      • image
      • image
      • image
      • image
      • image
      • image
  15. PHARMACOLOGY OF PERIVASCULAR ADIPOSE TISSUE

    1. Exercise effects on perivascular adipose tissue: endocrine and paracrine determinants of vascular function

      B C S Boa, J S Yudkin, V W M van Hinsbergh, E Bouskela and E C Eringa

      Version of Record online: 16 MAR 2017 | DOI: 10.1111/bph.13732

      • image
      • image
  16. RESEARCH PAPERS

    1. Broad spectrum efficacy with LY2969822, an oral prodrug of metabotropic glutamate 2/3 receptor agonist LY2934747, in rodent pain models

      Michael P Johnson, Mark A Muhlhauser, Eric S Nisenbaum, Rosa M A Simmons, Beth M Forster, Kelly L Knopp, Lijuan Yang, Denise Morrow, Dominic L Li, Jeffrey D Kennedy, Steven Swanson and James A Monn

      Version of Record online: 13 MAR 2017 | DOI: 10.1111/bph.13740

      • image
      • image
      • image
      • image
      • image
      • image
      • image
      • image
      • image
    2. Identification and pharmacological characterization of succinate receptor agonists

      Pierre Geubelle, Julie Gilissen, Sébastien Dilly, Laurence Poma, Nadine Dupuis, Céline Laschet, Dayana Abboud, Asuka Inoue, François Jouret, Bernard Pirotte and Julien Hanson

      Version of Record online: 10 MAR 2017 | DOI: 10.1111/bph.13738

      • image
      • image
      • image
      • image
      • image
      • image
    3. Pharmacological characterization of the excitatory ‘Cys-loop’ GABA receptor family in Caenorhabditis elegans

      Georgina C B Nicholl, Ali K Jawad, Robert Weymouth, Haoming Zhang and Asim A Beg

      Version of Record online: 10 MAR 2017 | DOI: 10.1111/bph.13736

      • image
      • image
      • image
      • image
      • image
      • image
      • image
      • image
  17. IUPHAR REVIEWS

    1. Significance of angiotensin 1–7 coupling with MAS1 receptor and other GPCRs to the renin-angiotensin system: IUPHAR Review 22

      Sadashiva S Karnik, Khuraijam Dhanachandra Singh, Kalyan Tirupula and Hamiyet Unal

      Version of Record online: 9 MAR 2017 | DOI: 10.1111/bph.13742

      • image
      • image
  18. RESEARCH PAPERS

    1. You have full text access to this OnlineOpen article
      Dapagliflozin-lowered blood glucose reduces respiratory Pseudomonas aeruginosa infection in diabetic mice

      Annika Åstrand, Cecilia Wingren, Audra Benjamin, John S Tregoning, James P Garnett, Helen Groves, Simren Gill, Maria Orogo-Wenn, Anders J Lundqvist, Dafydd Walters, David M Smith, John D Taylor, Emma H Baker and Deborah L Baines

      Version of Record online: 9 MAR 2017 | DOI: 10.1111/bph.13741

      • image
      • image
      • image
      • image
      • image
      • image
      • image
      • image
  19. PHARMACOLOGY OF COGNITION

    1. You have free access to this content
      Cannabidiol regulation of emotion and emotional memory processing: relevance for treating anxiety-related and substance abuse disorders

      Jonathan L C Lee, Leandro J Bertoglio, Francisco S Guimarães and Carl W Stevenson

      Version of Record online: 9 MAR 2017 | DOI: 10.1111/bph.13724

      • image
  20. RESEARCH PAPERS

    1. Effects of linagliptin on human immortalized podocytes: a cellular system to study dipeptidyl-peptidase 4 inhibition

      Gianluca Miglio, Giovanna Vitarelli, Thomas Klein and Elisa Benetti

      Version of Record online: 6 MAR 2017 | DOI: 10.1111/bph.13739

      • image
      • image
      • image
      • image
      • image
      • image
      • image
      • image
      • image
  21. REDOX BIOLOGY AND OXIDATIVE STRESS IN HEALTH AND DISEASE

    1. Biomarkers of oxidative and nitro-oxidative stress: conventional and novel approaches

      Ana Cipak Gasparovic, Neven Zarkovic, Kamelija Zarkovic, Khrystyna Semen, Danylo Kaminskyy, Olha Yelisyeyeva and Serge P. Bottari

      Version of Record online: 6 MAR 2017 | DOI: 10.1111/bph.13673

      • image
      • image
      • image
      • image
  22. DRUG REPURPOSING

  23. PHARMACOLOGY OF PERIVASCULAR ADIPOSE TISSUE

    1. Role of PVAT in coronary atherosclerosis and vein graft patency: friend or foe?

      M S Fernández-Alfonso, M Gil-Ortega, I Aranguez, D Souza, M Dreifaldt, B Somoza and M R Dashwood

      Version of Record online: 2 MAR 2017 | DOI: 10.1111/bph.13734

      • image
      • image
      • image
      • image
  24. RELAXIN

    1. Relaxin-like peptides in male reproduction – a human perspective

      Richard Ivell, Alexander I Agoulnik and Ravinder Anand-Ivell

      Version of Record online: 27 FEB 2017 | DOI: 10.1111/bph.13689

      • image
      • image
      • image
  25. CARDIOTOXICITY

    1. 5-fluorouracil causes endothelial cell senescence: potential protective role of glucagon-like peptide 1

      Paola Altieri, Roberto Murialdo, Chiara Barisione, Edoardo Lazzarini, Silvano Garibaldi, Patrizia Fabbi, Clarissa Ruggeri, Silvia Borile, Federico Carbone, Andrea Armirotti, Marco Canepa, Alberto Ballestrero, Claudio Brunelli, Fabrizio Montecucco, Pietro Ameri and Paolo Spallarossa

      Version of Record online: 22 FEB 2017 | DOI: 10.1111/bph.13725

      • image
      • image
      • image
      • image
      • image
      • image
      • image
  26. DRUG REPURPOSING

    1. β-Caryophyllene protects against alcoholic steatohepatitis by attenuating inflammation and metabolic dysregulation in mice

      Zoltan V. Varga, Csaba Matyas, Katalin Erdelyi, Resat Cinar, Daniela Nieri, Andrea Chicca, Balazs Tamas Nemeth, Janos Paloczi, Tamas Lajtos, Lukas Corey, Gyorgy Hasko, Bin Gao, George Kunos, Jürg Gertsch and Pal Pacher

      Version of Record online: 22 FEB 2017 | DOI: 10.1111/bph.13722

      • image
      • image
      • image
      • image
      • image
      • image
      • image
      • image
  27. TARGETING INFLAMMATION TO REDUCE CVD RISK: A REALISTIC CLINICAL PROSPECT

    1. Aspirin-triggered lipoxin A4 inhibits atherosclerosis progression in apolipoprotein E−/− mice

      Marcelo H Petri, Andrés Laguna-Fernandez, Hildur Arnardottir, Craig E Wheelock, Mauro Perretti, Göran K Hansson and Magnus Bäck

      Version of Record online: 14 FEB 2017 | DOI: 10.1111/bph.13707

      • image
      • image
      • image
      • image
      • image
      • image
  28. PHARMACOLOGY OF PERIVASCULAR ADIPOSE TISSUE

    1. Perivascular adipose tissue inflammation in vascular disease

      Ryszard Nosalski and Tomasz J Guzik

      Version of Record online: 9 FEB 2017 | DOI: 10.1111/bph.13705

      • image
      • image
      • image
  29. CARDIOTOXICITY

    1. Chronic drug-induced effects on contractile motion properties and cardiac biomarkers in human induced pluripotent stem cell-derived cardiomyocytes

      Ivan Kopljar, An De Bondt, Petra Vinken, Ard Teisman, Bruce Damiano, Nick Goeminne, Ilse Van den Wyngaert, David J Gallacher and Hua Rong Lu

      Version of Record online: 8 FEB 2017 | DOI: 10.1111/bph.13713

      • image
      • image
      • image
      • image
      • image
      • image
      • image
      • image
      • image
  30. REDOX BIOLOGY AND OXIDATIVE STRESS IN HEALTH AND DISEASE

    1. Effect of hypercholesterolaemia on myocardial function, ischaemia–reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioning

      Ioanna Andreadou, Efstathios K Iliodromitis, Antigone Lazou, Anikó Görbe, Zoltán Giricz, Rainer Schulz and Péter Ferdinandy

      Version of Record online: 8 FEB 2017 | DOI: 10.1111/bph.13704

      • image
  31. PRINCIPLES OF PHARMACOLOGICAL RESEARCH OF NUTRACEUTICALS

    1. Bioactive polyphenols and cardiovascular disease: chemical antagonists, pharmacological agents or xenobiotics that drive an adaptive response?

      Katarzyna Goszcz, Garry G Duthie, Derek Stewart, Stephen J Leslie and Ian L Megson

      Version of Record online: 2 FEB 2017 | DOI: 10.1111/bph.13708

      • image
      • image
      • image
      • image
      • image
      • image
      • image
  32. DRUG METABOLISM AND ANTIBIOTIC RESISTANCE IN MICRO-ORGANISMS

    1. Novel approaches to the treatment of bacterial biofilm infections

      Gareth Hughes and Mark A Webber

      Version of Record online: 2 FEB 2017 | DOI: 10.1111/bph.13706

      • image
      • image
  33. TARGETING INFLAMMATION TO REDUCE CVD RISK: A REALISTIC CLINICAL PROSPECT

    1. Anti-atherosclerotic effect of the angiotensin 1–7 mimetic AVE0991 is mediated by inhibition of perivascular and plaque inflammation in early atherosclerosis

      D S Skiba, R Nosalski, T P Mikolajczyk, M Siedlinski, F J Rios, A C Montezano, J Jawien, R Olszanecki, R Korbut, M Czesnikiewicz-Guzik, R M Touyz and T J Guzik

      Version of Record online: 1 FEB 2017 | DOI: 10.1111/bph.13685

      • image
      • image
      • image
      • image
      • image
  34. PHARMACOLOGY OF PERIVASCULAR ADIPOSE TISSUE

    1. You have full text access to this OnlineOpen article
      Restoration of perivascular adipose tissue function in diet-induced obese mice without changing bodyweight

      Ning Xia, Sabrina Weisenburger, Egon Koch, Martin Burkart, Gisela Reifenberg, Ulrich Förstermann and Huige Li

      Version of Record online: 31 JAN 2017 | DOI: 10.1111/bph.13703

      • image
      • image
      • image
      • image
      • image
      • image
  35. RELAXIN

  36. DRUG METABOLISM AND ANTIBIOTIC RESISTANCE IN MICRO-ORGANISMS

    1. You have free access to this content
  37. PHARMACOLOGY OF PERIVASCULAR ADIPOSE TISSUE

  38. RELAXIN

    1. Relaxin family peptides: structure–activity relationship studies

      Nitin A Patil, K Johan Rosengren, Frances Separovic, John D Wade, Ross A D Bathgate and Mohammed Akhter Hossain

      Version of Record online: 19 JAN 2017 | DOI: 10.1111/bph.13684

      • image
      • image
      • image
      • image
      • image
      • image
  39. PRINCIPLES OF PHARMACOLOGICAL RESEARCH OF NUTRACEUTICALS

  40. PHARMACOLOGY OF PERIVASCULAR ADIPOSE TISSUE

    1. Increased mitochondrial ROS generation mediates the loss of the anti-contractile effects of perivascular adipose tissue in high-fat diet obese mice

      Rafael Menezes da Costa, Rafael S Fais, Carlos R P Dechandt, Paulo Louzada-Junior, Luciane C Alberici, Núbia S Lobato and Rita C Tostes

      Version of Record online: 12 JAN 2017 | DOI: 10.1111/bph.13687

      • image
      • image
      • image
      • image
      • image
  41. DRUG METABOLISM AND ANTIBIOTIC RESISTANCE IN MICRO-ORGANISMS

    1. The role of apolipoprotein N-acyl transferase, Lnt, in the lipidation of factor H binding protein of Neisseria meningitidis strain MC58 and its potential as a drug target

      R A G da Silva, C P Churchward, A V Karlyshev, O Eleftheriadou, A K Snabaitis, M R Longman, A Ryan and R Griffin

      Version of Record online: 21 DEC 2016 | DOI: 10.1111/bph.13660

      • image
      • image
      • image
      • image
      • image
      • image
      • image
  42. PHARMACOLOGY OF PERIVASCULAR ADIPOSE TISSUE

    1. Perivascular adipose tissue as a regulator of vascular disease pathogenesis: identifying novel therapeutic targets

      Ioannis Akoumianakis, Akansha Tarun and Charalambos Antoniades

      Version of Record online: 14 DEC 2016 | DOI: 10.1111/bph.13666

      • image
  43. DRUG METABOLISM AND ANTIBIOTIC RESISTANCE IN MICRO-ORGANISMS

  44. PHARMACOLOGY OF PERIVASCULAR ADIPOSE TISSUE

    1. New actions of an old friend: perivascular adipose tissue's adrenergic mechanisms

      Nadia Ayala-Lopez and Stephanie W Watts

      Version of Record online: 4 DEC 2016 | DOI: 10.1111/bph.13663

      • image
  45. RELAXIN

    1. Distribution, physiology and pharmacology of relaxin-3/RXFP3 systems in brain

      Sherie Ma, Craig M Smith, Anna Blasiak and Andrew L Gundlach

      Version of Record online: 4 DEC 2016 | DOI: 10.1111/bph.13659

      • image
      • image
      • image
      • image
      • image
    2. Synthetic non-peptide low molecular weight agonists of the relaxin receptor 1

      Alexander I Agoulnik, Irina U Agoulnik, Xin Hu and Juan Marugan

      Version of Record online: 30 NOV 2016 | DOI: 10.1111/bph.13656

      • image
      • image
      • image
      • image
  46. CARDIOTOXICITY

    1. Trastuzumab cardiotoxicity: from clinical trials to experimental studies

      Balazs T Nemeth, Zoltan V Varga, Wen Jin Wu and Pal Pacher

      Version of Record online: 25 NOV 2016 | DOI: 10.1111/bph.13643

      • image
      • image
  47. PHARMACOLOGY OF PERIVASCULAR ADIPOSE TISSUE

    1. You have full text access to this OnlineOpen article
  48. DRUG REPURPOSING

    1. Development of a stretch-induced neurotrauma model for medium-throughput screening in vitro: identification of rifampicin as a neuroprotectant

      Isabel López-García, Domokos Gerő, Bartosz Szczesny, Petra Szoleczky, Gabor Olah, Katalin Módis, Kangling Zhang, Jungling Gao, Ping Wu, Lawrence C Sowers, Doug DeWitt, Donald S Prough and Csaba Szabo

      Version of Record online: 15 NOV 2016 | DOI: 10.1111/bph.13642

      • image
      • image
      • image
      • image
      • image
      • image
      • image
      • image
      • image
      • image
  49. PRINCIPLES OF PHARMACOLOGICAL RESEARCH OF NUTRACEUTICALS

  50. DRUG METABOLISM AND ANTIBIOTIC RESISTANCE IN MICRO-ORGANISMS

    1. Xenobiotic-metabolizing enzymes in Bacillus anthracis: molecular and functional analysis of a truncated arylamine N-acetyltransferase isozyme

      Xavier Kubiak, Romain Duval, Benjamin Pluvinage, Alain F Chaffotte, Jean-Marie Dupret and Fernando Rodrigues-Lima

      Version of Record online: 12 NOV 2016 | DOI: 10.1111/bph.13647

      • image
      • image
      • image
      • image
  51. PRINCIPLES OF PHARMACOLOGICAL RESEARCH OF NUTRACEUTICALS

    1. An orally administered butyrate-releasing derivative reduces neutrophil recruitment and inflammation in dextran sulphate sodium-induced murine colitis

      Raffaele Simeoli, Giuseppina Mattace Raso, Claudio Pirozzi, Adriano Lama, Anna Santoro, Roberto Russo, Trinidad Montero-Melendez, Roberto Berni Canani, Antonio Calignano, Mauro Perretti and Rosaria Meli

      Version of Record online: 3 NOV 2016 | DOI: 10.1111/bph.13637

      • image
      • image
      • image
      • image
      • image
      • image
    2. You have full text access to this OnlineOpen article
      Nutraceuticals in hypercholesterolaemia: an overview

      Antonello Santini and Ettore Novellino

      Version of Record online: 29 OCT 2016 | DOI: 10.1111/bph.13636

      • image
      • image
      • image
    3. Carotenoids: biochemistry, pharmacology and treatment

      Alireza Milani, Marzieh Basirnejad, Sepideh Shahbazi and Azam Bolhassani

      Version of Record online: 29 OCT 2016 | DOI: 10.1111/bph.13625

      • image
      • image
    4. Probiotics, fibre and herbal medicinal products for functional and inflammatory bowel disorders

      Diego Currò, Gianluca Ianiro, Silvia Pecere, Stefano Bibbò and Giovanni Cammarota

      Version of Record online: 25 OCT 2016 | DOI: 10.1111/bph.13632

    5. Effects of anthocyanins on the prevention and treatment of cancer

      Bo-Wen Lin, Cheng-Chen Gong, Hai-Fei Song and Ying-Yu Cui

      Version of Record online: 25 OCT 2016 | DOI: 10.1111/bph.13627

      • image
      • image
  52. PHARMACOLOGY OF PERIVASCULAR ADIPOSE TISSUE

    1. Deletion of AMPKα1 attenuates the anticontractile effect of perivascular adipose tissue (PVAT) and reduces adiponectin release

      Tarek A M Almabrouk, Azizah B Ugusman, Omar J Katwan, Ian P Salt and Simon Kennedy

      Version of Record online: 23 OCT 2016 | DOI: 10.1111/bph.13633

      • image
      • image
      • image
      • image
      • image
      • image
      • image
  53. PRINCIPLES OF PHARMACOLOGICAL RESEARCH OF NUTRACEUTICALS

    1. Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases

      Ajaikumar B Kunnumakkara, Devivasha Bordoloi, Ganesan Padmavathi, Javadi Monisha, Nand Kishor Roy, Sahdeo Prasad and Bharat B Aggarwal

      Version of Record online: 21 OCT 2016 | DOI: 10.1111/bph.13621

      • image
      • image
    2. Proanthocyanidins and hydrolysable tannins: occurrence, dietary intake and pharmacological effects

      Antonella Smeriglio, Davide Barreca, Ersilia Bellocco and Domenico Trombetta

      Version of Record online: 21 OCT 2016 | DOI: 10.1111/bph.13630

      • image
      • image
      • image
      • image
    3. You have full text access to this OnlineOpen article
      The potential health effects of dietary phytoestrogens

      Ivonne M C M Rietjens, Jochem Louisse and Karsten Beekmann

      Version of Record online: 20 OCT 2016 | DOI: 10.1111/bph.13622

      • image
      • image
      • image
      • image
      • image
  54. TARGETING INFLAMMATION TO REDUCE CVD RISK: A REALISTIC CLINICAL PROSPECT

    1. Unravelling the adiponectin paradox: novel roles of adiponectin in the regulation of cardiovascular disease

      Lavinia Woodward, Ioannis Akoumianakis and Charalambos Antoniades

      Version of Record online: 19 OCT 2016 | DOI: 10.1111/bph.13619

      • image
    2. Proteinase activated receptor-2 counterbalances the vascular effects of endothelin-1 in fibrotic tight-skin mice

      Fiorentina Roviezzo, Vincenzo Brancaleone, Valentina Mattera Iacono, Antonio Bertolino, Giovanna De Cunto, Valentina Vellecco, Giuseppe Lungarella, Monica Lucattelli and Giuseppe Cirino

      Version of Record online: 5 OCT 2016 | DOI: 10.1111/bph.13618

      • image
      • image
      • image
      • image
      • image
      • image
    3. T-cell immunity in myocardial inflammation: pathogenic role and therapeutic manipulation

      E Stephenson, K Savvatis, S A Mohiddin and F M Marelli-Berg

      Version of Record online: 4 OCT 2016 | DOI: 10.1111/bph.13613

      • image
  55. RELAXIN

    1. Vascular actions of relaxin: nitric oxide and beyond

      C H Leo, M Jelinic, H H Ng, S A Marshall, J Novak, M Tare, K P Conrad and L J Parry

      Version of Record online: 30 SEP 2016 | DOI: 10.1111/bph.13614

      • image
      • image
  56. PRINCIPLES OF PHARMACOLOGICAL RESEARCH OF NUTRACEUTICALS

    1. Potential role of bioactive peptides in prevention and treatment of chronic diseases: a narrative review

      Arrigo F G Cicero, Federica Fogacci and Alessandro Colletti

      Version of Record online: 29 SEP 2016 | DOI: 10.1111/bph.13608

      • image
      • image
      • image
  57. CARDIOTOXICITY

    1. You have full text access to this OnlineOpen article
  58. RELAXIN

    1. You have full text access to this OnlineOpen article
      Relaxin’ the brain: a case for targeting the nucleus incertus network and relaxin-3/RXFP3 system in neuropsychiatric disorders

      Jigna Rajesh Kumar, Ramamoorthy Rajkumar, Tharindunee Jayakody, Subhi Marwari, Jia Mei Hong, Sherie Ma, Andrew L Gundlach, Mitchell K P Lai and Gavin S Dawe

      Version of Record online: 6 SEP 2016 | DOI: 10.1111/bph.13564

      • image
      • image
  59. DRUG METABOLISM AND ANTIBIOTIC RESISTANCE IN MICRO-ORGANISMS

    1. Azoreductases in drug metabolism

      Ali Ryan

      Version of Record online: 2 SEP 2016 | DOI: 10.1111/bph.13571

      • image
      • image
      • image
      • image
      • image
      • image
  60. REDOX BIOLOGY AND OXIDATIVE STRESS IN HEALTH AND DISEASE

    1. Redox-based therapeutics in neurodegenerative disease

      G J McBean, M G López and F K Wallner

      Version of Record online: 25 AUG 2016 | DOI: 10.1111/bph.13551

      • image
      • image
      • image
      • image
    2. Glucagon-like peptide-1 receptor signalling reduces microvascular thrombosis, nitro-oxidative stress and platelet activation in endotoxaemic mice

      Sebastian Steven, Kerstin Jurk, Maximilian Kopp, Swenja Kröller-Schön, Yuliya Mikhed, Kathrin Schwierczek, Siyer Roohani, Fatemeh Kashani, Matthias Oelze, Thomas Klein, Sergey Tokalov, Sven Danckwardt, Susanne Strand, Philip Wenzel, Thomas Münzel and Andreas Daiber

      Version of Record online: 21 AUG 2016 | DOI: 10.1111/bph.13549

      • image
      • image
      • image
      • image
      • image
      • image
  61. RELAXIN

    1. Structural commonality of C1q TNF-related proteins and their potential to activate relaxin/insulin-like family peptide receptor 1 signalling pathways in cancer cells

      Thomas Klonisch, Aleksandra Glogowska, Thatchawan Thanasupawat, Maxwell Burg, Jerry Krcek, Marshall Pitz, Appalaraju Jaggupilli, Prashen Chelikani, G William Wong and Sabine Hombach-Klonisch

      Version of Record online: 11 AUG 2016 | DOI: 10.1111/bph.13559

      • image
      • image
      • image
  62. PRINCIPLES OF PHARMACOLOGICAL RESEARCH OF NUTRACEUTICALS

    1. Anti-inflammatory and analgesic activity of carnosol and carnosic acid in vivo and in vitro and in silico analysis of their target interactions

      Francesco Maione, Vincenza Cantone, Simona Pace, Maria Giovanna Chini, Angela Bisio, Giovanni Romussi, Stefano Pieretti, Oliver Werz, Andreas Koeberle, Nicola Mascolo and Giuseppe Bifulco

      Version of Record online: 8 AUG 2016 | DOI: 10.1111/bph.13545

      • image
      • image
      • image
      • image
      • image
      • image
      • image
      • image
  63. REDOX BIOLOGY AND OXIDATIVE STRESS IN HEALTH AND DISEASE

    1. The oxidative stress theory of disease: levels of evidence and epistemological aspects

      Pietro Ghezzi, Vincent Jaquet, Fabrizio Marcucci and Harald H H W Schmidt

      Version of Record online: 4 AUG 2016 | DOI: 10.1111/bph.13544

      • image
      • image
      • image
      • image
      • image
      • image
      • image
    2. Therapeutic potential of NADPH oxidase 1/4 inhibitors

      G Teixeira, C Szyndralewiez, S Molango, S Carnesecchi, F Heitz, P Wiesel and J M Wood

      Version of Record online: 14 JUL 2016 | DOI: 10.1111/bph.13532

  64. RELAXIN

    1. Signal transduction pathways activated by insulin-like peptide 5 at the relaxin family peptide RXFP4 receptor

      Sheng Y Ang, Dana S Hutchinson, Nitin Patil, Bronwyn A Evans, Ross A D Bathgate, Michelle L Halls, Mohammed A Hossain, Roger J Summers and Martina Kocan

      Version of Record online: 13 JUL 2016 | DOI: 10.1111/bph.13522

      • image
      • image
      • image
      • image
      • image
      • image
      • image
    2. Sex-specific effects of relaxin-3 on food intake and body weight gain

      Juliane Calvez, Camila de Ávila and Elena Timofeeva

      Version of Record online: 13 JUL 2016 | DOI: 10.1111/bph.13530

      • image
      • image
      • image
      • image
      • image
    3. The actions of relaxin on the human cardiovascular system

      Mohsin Sarwar, Xiao-Jun Du, Thomas B Dschietzig and Roger J Summers

      Version of Record online: 11 JUL 2016 | DOI: 10.1111/bph.13523

      • image
      • image
      • image
      • image
      • image
    4. Anti-fibrotic actions of relaxin

      C S Samuel, S G Royce, T D Hewitson, K M Denton, T E Cooney and R G Bennett

      Version of Record online: 7 JUL 2016 | DOI: 10.1111/bph.13529

      • image
  65. REDOX BIOLOGY AND OXIDATIVE STRESS IN HEALTH AND DISEASE

    1. Targeting vascular (endothelial) dysfunction

      Andreas Daiber, Sebastian Steven, Alina Weber, Vladimir V. Shuvaev, Vladimir R. Muzykantov, Ismail Laher, Huige Li, Santiago Lamas and Thomas Münzel

      Version of Record online: 4 JUL 2016 | DOI: 10.1111/bph.13517

      • image
      • image
      • image
      • image
      • image
    2. You have free access to this content
      Targeting the NO/superoxide ratio in adipose tissue: relevance to obesity and diabetes management

      Aleksandra Jankovic, Aleksandra Korac, Biljana Buzadzic, Ana Stancic, Vesna Otasevic, Péter Ferdinandy, Andreas Daiber and Bato Korac

      Version of Record online: 15 MAY 2016 | DOI: 10.1111/bph.13498

      • image
      • image
      • image
      • image
    3. You have free access to this content
      Antioxidant effects of resveratrol in the cardiovascular system

      Ning Xia, Andreas Daiber, Ulrich Förstermann and Huige Li

      Version of Record online: 6 MAY 2016 | DOI: 10.1111/bph.13492

      • image
  66. RELAXIN

    1. Relaxin and insulin-like peptide 3 in the musculoskeletal system: from bench to bedside

      Alberto Ferlin, Luca De Toni, Marco Sandri and Carlo Foresta

      Version of Record online: 5 MAY 2016 | DOI: 10.1111/bph.13490

      • image
      • image
      • image
  67. REDOX BIOLOGY AND OXIDATIVE STRESS IN HEALTH AND DISEASE

    1. New aspects of p66Shc in ischaemia reperfusion injury and other cardiovascular diseases

      Fabio Di Lisa, Marco Giorgio, Peter Ferdinandy and Rainer Schulz

      Version of Record online: 14 APR 2016 | DOI: 10.1111/bph.13478

      • image
      • image
    2. You have free access to this content
      ROS in gastrointestinal inflammation: Rescue Or Sabotage?

      G Aviello and UG Knaus

      Version of Record online: 3 MAR 2016 | DOI: 10.1111/bph.13428

      • image
      • image
      • image
    3. You have free access to this content
      Microglia antioxidant systems and redox signalling

      F Vilhardt, J Haslund-Vinding, V Jaquet and G McBean

      Version of Record online: 3 MAR 2016 | DOI: 10.1111/bph.13426

      • image
    4. You have free access to this content
    5. You have free access to this content
      Crosstalk of mitochondria with NADPH oxidase via reactive oxygen and nitrogen species signalling and its role for vascular function

      Andreas Daiber, Fabio Di Lisa, Matthias Oelze, Swenja Kröller-Schön, Sebastian Steven, Eberhard Schulz and Thomas Münzel

      Version of Record online: 4 FEB 2016 | DOI: 10.1111/bph.13403

      • image
      • image
      • image
      • image
      • image

VIEW

  1. 1 - 97

SEARCH

SEARCH BY CITATION